IEG Policy is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glucosamine supplements may be linked to lower risk of cardiovascular disease

Further clinical trials are needed to test this theory, say the researchers.

This article is powered by EU Food Law

A study published in the British Medical Journal (BMJ) this week has found that regular use of glucosamine supplements could be related to a lower risk of cardiovascular disease (CVD) events, such as heart disease and stroke.

Advertisement

Related Content

Topics

What to read next

UsernamePublicRestriction

Register

PL220236

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel